Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: "Sophia Stock,corresponding author#1,2,3 Mohamed-Reda Benmebarek,#1,4 Anna-Kristina Kluever,1 Diana Darowski,5,6 Christian Jost,5,7 Kay-Gunnar Stubenrauch,8 Joerg Benz,9 Anne Freimoser-Grundschober,5 Ekkehard Moessner,5 Pablo Umana,5 Marion Subklewe,2,3 Stefan Endres,1,3,10 Christian Klein,corresponding author5 and Sebastian Koboldcorresponding author"

Journal title: Journal for the Immunotherapy of Cancer

Journal publisher: BMJ

Published year: 2022

DOI identifier: 10.1136/jitc-2022-005054

ISSN: 2051-1426